Drug application
LUMENHANCE (MANGANESE CHLORIDE TETRAHYDRATE)
Drugs@FDA NDA 020686 · BRACCO
Key facts
| Drug name | LUMENHANCE |
|---|---|
| Active ingredients | MANGANESE CHLORIDE TETRAHYDRATE |
| Application type | NDA |
| Application number | 020686 |
| Company | BRACCO |
| Dosage forms | FOR SOLUTION, ORAL |
| Strength | 3.49MG/GM |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Dec 19, 1997 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.